<DOC>
	<DOCNO>NCT01557946</DOCNO>
	<brief_summary>Primarily , study seek evaluate whether citalopram treatment associate increase Glutamine ( Gln ) /Glutamate ( Glu ) ratio anterior cingulate cortex ( ACC ) baseline day 3 treatment . Additionally , study would like examine whether citalopram treatment associate increase Gln/Glu ratio ACC baseline day 7 treatment .</brief_summary>
	<brief_title>Glutamatergic GABAergic Mediators Antidepressant Response Major Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<criteria>1 . Male female age ≥ 18 ≤ 65 2 . Meets DSMIV criterion MDD 3 . Current score ≥ 18 21item Hamilton Depression Rating Scale ( HAMD ) . 1 . Unwillingness inability provide write informed consent . 2 . Current suicidal ideation 3 . Active psychotic symptom 4 . Lifetime history bipolar disorder , schizophrenia , OCD 5 . Failed treatment adequate trial ≥ 2 antidepressant current major depressive episode ( `` failure '' define ≤ 50 % subjective improvement , `` adequate trial '' define least 4 week treatment use least minimum dose antidepressant recommend manufacturer product label ) 6 . DSMIV diagnosis alcohol substance dependence , exception nicotine dependence , within three month prior screen 7 . Any history treatment electroconvulsive therapy 8 . Positive urine toxicology screen drug abuse exclude medication screening . Opiate pain medication take medical condition exempt need negative opiate screen . 9 . Clinically significant medical neurologic disease , judge principal investigator , would increase risk participant interfere interpretation result 10 . Female participant positive urine pregnancy test screen 12 . Pregnancy . Females childbearing potential must use effective contraceptive method ( e.g. , abstinence , prescription oral contraceptive , contraceptive injection , doublebarrier method , male partner sterilization ) . 13 . Any screening laboratory abnormality deem clinically significant investigator 14 . A QTc interval screen ECG ≥ 450 msec . 15 . Use excluded medication ( see Section 6.7 ) discontinue screen phase 16 . Previous failure respond treatment citalopram would , judgment investigator , constitute adequate trial MDD 17 . Treatment investigational medication within 30 day prior screen 18 . Any contraindication MRI scan , include cardiac pacemaker , metal vascular clip stent , artificial heart valve , certain kind prosthesis , brain stimulator device , implant drug pump , ear implant , eye implant know metal fragment eye , exposure shrapnel metal filing ( wounded military combat , sheetmetal worker , welder , others ) , transdermal drug delivery system , certain tattoos metallic ink 19 . Lefthandedness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>